Collagenase Clostridium histolyticum (CCH; Xiapex) injections represent the only licensed medical treatment for Peyronie's disease (PD).
Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study / Cocci, A., Russo, G.I., Salonia, A., Cito, G., Regis, F., Polloni, G., Giubilei, G., Cacciamani, G., Capece, M., Falcone, M., Greco, I., Timpano, M., Minervini, A., Gacci, M., Cai, T., Garaffa, G., Giammusso, B., Arcaniolo, D., Mirone, V., Mondaini, N.. - In: THE JOURNAL OF SEXUAL MEDICINE. - ISSN 1743-6109. - ELETTRONICO. - 15:5(2018), pp. 716-721. [10.1016/j.jsxm.2018.03.084]
Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study
Cai, Tommaso;
2018-01-01
Abstract
Collagenase Clostridium histolyticum (CCH; Xiapex) injections represent the only licensed medical treatment for Peyronie's disease (PD).| File | Dimensione | Formato | |
|---|---|---|---|
|
cocci2018 (1).pdf
Solo gestori archivio
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
218.21 kB
Formato
Adobe PDF
|
218.21 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione
